Señales en vivo de CYBN | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 16:00):

Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to treat neuroinflammation...

Stats
Volumen de hoy	2.72M
Volumen promedio	5.44M
Capitalización de mercado	265.89M
EPS	$0 ( 2024-02-13 )
Próxima fecha de ganancias	( $-0.0300 ) 2024-06-25
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.590
ATR14	$0.00100 (0.29%)

Volumen Correlación

Largo: -0.06 (neutral)

Corto: 0.88 (strong)

Signal:(55.869) Same movement expected

Cybin Inc. Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Cybin Inc. Correlación - Moneda/Commodity

0.00
( neutral )

Cybin Inc. Finanzas

Annual	2022
Ingresos:	$0
Beneficio Bruto:	$-251 000 (0.00 %)
EPS:	$-0.220

FY	2022
Ingresos:	$0
Beneficio Bruto:	$-251 000 (0.00 %)
EPS:	$-0.220

FY	2022
Ingresos:	$0
Beneficio Bruto:	$0 (0.00 %)
EPS:	$-0.430

FY	2021
Ingresos:	$864 000
Beneficio Bruto:	$200 000 (23.15 %)
EPS:	$-0.320

Financial Reports:

No articles found.

Cybin Inc.